$MRNA Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Moderna, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Moderna, Inc.. Get notifications about new insider transactions in Moderna, Inc. for free.
Page: < prev 1 ... 7 8 9 10 11 12 13 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 26 2020 | MRNA | Moderna, Inc. | Flagship Ventures Fund IV Gene ... | Director | Sell | S | 71.51 | 2,551 | 182,433 | 6,501,133 | 6.5 M to 6.5 M (-0.04 %) |
May 26 2020 | MRNA | Moderna, Inc. | Flagship Ventures Fund IV Gene ... | Director | Sell | S | 70.46 | 3,900 | 274,780 | 6,503,684 | 6.5 M to 6.5 M (-0.06 %) |
May 26 2020 | MRNA | Moderna, Inc. | Flagship Ventures Fund IV Gene ... | Director | Sell | S | 68.81 | 7,443 | 512,185 | 6,507,584 | 6.5 M to 6.5 M (-0.11 %) |
May 26 2020 | MRNA | Moderna, Inc. | Flagship Ventures Fund IV Gene ... | Director | Sell | S | 67.15 | 23,199 | 1,557,822 | 6,515,027 | 6.5 M to 6.5 M (-0.35 %) |
May 26 2020 | MRNA | Moderna, Inc. | Flagship Ventures Fund IV Gene ... | Director | Sell | S | 65.77 | 42,540 | 2,797,690 | 6,538,226 | 6.6 M to 6.5 M (-0.65 %) |
May 26 2020 | MRNA | Moderna, Inc. | Flagship Ventures Fund IV Gene ... | Director | Sell | S | 72.44 | 1,933 | 140,017 | 22,406,399 | 22.4 M to 22.4 M (-0.01 %) |
May 26 2020 | MRNA | Moderna, Inc. | Flagship Ventures Fund IV Gene ... | Director | Sell | S | 71.51 | 13,408 | 958,861 | 22,408,332 | 22.4 M to 22.4 M (-0.06 %) |
May 26 2020 | MRNA | Moderna, Inc. | Flagship Ventures Fund IV Gene ... | Director | Sell | S | 70.46 | 20,492 | 1,443,793 | 22,421,740 | 22.4 M to 22.4 M (-0.09 %) |
May 26 2020 | MRNA | Moderna, Inc. | Flagship Ventures Fund IV Gene ... | Director | Sell | S | 68.81 | 39,082 | 2,689,404 | 22,442,232 | 22.5 M to 22.4 M (-0.17 %) |
May 26 2020 | MRNA | Moderna, Inc. | Flagship Ventures Fund IV Gene ... | Director | Sell | S | 67.15 | 121,771 | 8,176,971 | 22,481,314 | 22.6 M to 22.5 M (-0.54 %) |
May 26 2020 | MRNA | Moderna, Inc. | Flagship Ventures Fund IV Gene ... | Director | Sell | S | 65.77 | 223,314 | 14,686,491 | 22,603,085 | 22.8 M to 22.6 M (-0.98 %) |
May 26 2020 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 70.45 | 28 | 1,973 | 585,454 | 585.5 K to 585.5 K (0.00 %) |
May 26 2020 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 69.69 | 3,277 | 228,374 | 585,482 | 588.8 K to 585.5 K (-0.56 %) |
May 26 2020 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 68.74 | 6,503 | 447,016 | 588,759 | 595.3 K to 588.8 K (-1.09 %) |
May 26 2020 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 67.76 | 1,238 | 83,887 | 595,262 | 596.5 K to 595.3 K (-0.21 %) |
May 22 2020 | MRNA | Moderna, Inc. | HENDERSON LORI M. | General Counsel and ... | Option Exercise | M | 14.85 | 64,000 | 950,400 | 463,522 | |
May 22 2020 | MRNA | Moderna, Inc. | HENDERSON LORI M. | General Counsel and ... | Sell | S | 70.00 | 64,000 | 4,480,000 | 0 | 64 K to 0 (-100.00 %) |
May 22 2020 | MRNA | Moderna, Inc. | HENDERSON LORI M. | General Counsel and ... | Buy | M | 14.85 | 64,000 | 950,400 | 64,000 | 0 to 64 K |
May 20 2020 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Option Exercise | M | 12.21 | 112,481 | 1,373,393 | 346,234 | |
May 20 2020 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Option Exercise | M | 12.21 | 12,563 | 153,394 | 45,879 | |
May 20 2020 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Sell | S | 78.16 | 125,044 | 9,773,439 | 0 | 125 K to 0 (-100.00 %) |
May 20 2020 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Buy | M | 12.21 | 112,481 | 1,373,393 | 125,044 | 12.6 K to 125 K (+895.34 %) |
May 20 2020 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Buy | M | 12.21 | 12,563 | 153,394 | 12,563 | 0 to 12.6 K |
May 19 2020 | MRNA | Moderna, Inc. | Kim Lorence H. | Chief Financial Off ... | Option Exercise | M | 12.21 | 211,978 | 2,588,251 | 74,544 | |
May 19 2020 | MRNA | Moderna, Inc. | Kim Lorence H. | Chief Financial Off ... | Option Exercise | M | 14.22 | 29,022 | 412,693 | 888,409 | |
May 19 2020 | MRNA | Moderna, Inc. | Kim Lorence H. | Chief Financial Off ... | Sell | S | 86.96 | 798 | 69,394 | 1,202,510 | 1.2 M to 1.2 M (-0.07 %) |
May 19 2020 | MRNA | Moderna, Inc. | Kim Lorence H. | Chief Financial Off ... | Sell | S | 86.54 | 2,600 | 225,004 | 1,203,308 | 1.2 M to 1.2 M (-0.22 %) |
May 19 2020 | MRNA | Moderna, Inc. | Kim Lorence H. | Chief Financial Off ... | Sell | S | 85.16 | 5,868 | 499,719 | 1,205,908 | 1.2 M to 1.2 M (-0.48 %) |
May 19 2020 | MRNA | Moderna, Inc. | Kim Lorence H. | Chief Financial Off ... | Sell | S | 84.27 | 33,792 | 2,847,652 | 1,211,776 | 1.2 M to 1.2 M (-2.71 %) |
May 19 2020 | MRNA | Moderna, Inc. | Kim Lorence H. | Chief Financial Off ... | Sell | S | 83.33 | 59,175 | 4,931,053 | 1,245,568 | 1.3 M to 1.2 M (-4.54 %) |
May 19 2020 | MRNA | Moderna, Inc. | Kim Lorence H. | Chief Financial Off ... | Sell | S | 82.28 | 56,379 | 4,638,864 | 1,304,743 | 1.4 M to 1.3 M (-4.14 %) |
May 19 2020 | MRNA | Moderna, Inc. | Kim Lorence H. | Chief Financial Off ... | Sell | S | 81.43 | 16,736 | 1,362,812 | 1,361,122 | 1.4 M to 1.4 M (-1.21 %) |
May 19 2020 | MRNA | Moderna, Inc. | Kim Lorence H. | Chief Financial Off ... | Sell | S | 80.24 | 35,569 | 2,854,057 | 1,377,858 | 1.4 M to 1.4 M (-2.52 %) |
May 19 2020 | MRNA | Moderna, Inc. | Kim Lorence H. | Chief Financial Off ... | Sell | S | 79.40 | 18,675 | 1,482,795 | 1,413,427 | 1.4 M to 1.4 M (-1.30 %) |
May 19 2020 | MRNA | Moderna, Inc. | Kim Lorence H. | Chief Financial Off ... | Sell | S | 77.48 | 7,640 | 591,947 | 1,432,102 | 1.4 M to 1.4 M (-0.53 %) |
May 19 2020 | MRNA | Moderna, Inc. | Kim Lorence H. | Chief Financial Off ... | Sell | S | 76.45 | 3,768 | 288,064 | 1,439,742 | 1.4 M to 1.4 M (-0.26 %) |
May 19 2020 | MRNA | Moderna, Inc. | Kim Lorence H. | Chief Financial Off ... | Buy | M | 12.21 | 211,978 | 2,588,251 | 1,443,510 | 1.2 M to 1.4 M (+17.21 %) |
May 19 2020 | MRNA | Moderna, Inc. | Kim Lorence H. | Chief Financial Off ... | Buy | M | 14.22 | 29,022 | 412,693 | 1,231,532 | 1.2 M to 1.2 M (+2.41 %) |
May 19 2020 | MRNA | Moderna, Inc. | Kim Lorence H. | Chief Financial Off ... | Sell | S | 66.68 | 2,243 | 149,563 | 1,202,510 | 1.2 M to 1.2 M (-0.19 %) |
May 19 2020 | MRNA | Moderna, Inc. | Kim Lorence H. | Chief Financial Off ... | Sell | S | 66.05 | 9,715 | 641,676 | 1,204,753 | 1.2 M to 1.2 M (-0.80 %) |
May 19 2020 | MRNA | Moderna, Inc. | Kim Lorence H. | Chief Financial Off ... | Sell | S | 64.96 | 5,442 | 353,512 | 1,214,468 | 1.2 M to 1.2 M (-0.45 %) |
May 19 2020 | MRNA | Moderna, Inc. | Kim Lorence H. | Chief Financial Off ... | Sell | S | 63.80 | 2,600 | 165,880 | 1,219,910 | 1.2 M to 1.2 M (-0.21 %) |
May 19 2020 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 66.90 | 700 | 46,830 | 596,500 | 597.2 K to 596.5 K (-0.12 %) |
May 19 2020 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 66.11 | 5,809 | 384,033 | 597,200 | 603 K to 597.2 K (-0.96 %) |
May 19 2020 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 65.06 | 2,937 | 191,081 | 603,009 | 605.9 K to 603 K (-0.48 %) |
May 19 2020 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 63.91 | 1,600 | 102,256 | 605,946 | 607.5 K to 605.9 K (-0.26 %) |
May 19 2020 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Gift | G | 0.00 | 1,577 | 0 | 6,739,044 | 6.7 M to 6.7 M (-0.02 %) |
May 14 2020 | MRNA | Moderna, Inc. | Hoge Stephen | President | Sell | S | 66.26 | 700 | 46,382 | 2,006,540 | 2 M to 2 M (-0.03 %) |
May 14 2020 | MRNA | Moderna, Inc. | Hoge Stephen | President | Sell | S | 64.46 | 1,700 | 109,582 | 2,007,240 | 2 M to 2 M (-0.08 %) |
May 14 2020 | MRNA | Moderna, Inc. | Hoge Stephen | President | Sell | S | 65.28 | 1,674 | 109,279 | 2,008,940 | 2 M to 2 M (-0.08 %) |
May 14 2020 | MRNA | Moderna, Inc. | Hoge Stephen | President | Sell | S | 62.94 | 726 | 45,694 | 2,010,614 | 2 M to 2 M (-0.04 %) |
May 14 2020 | MRNA | Moderna, Inc. | Hoge Stephen | President | Sell | S | 60.77 | 200 | 12,154 | 2,011,340 | 2 M to 2 M (-0.01 %) |
May 14 2020 | MRNA | Moderna, Inc. | Hoge Stephen | President | Sell | S | 66.69 | 100 | 6,669 | 2,011,540 | 2 M to 2 M (0.00 %) |
May 14 2020 | MRNA | Moderna, Inc. | Hoge Stephen | President | Sell | S | 65.80 | 735 | 48,363 | 2,011,640 | 2 M to 2 M (-0.04 %) |
May 14 2020 | MRNA | Moderna, Inc. | Hoge Stephen | President | Sell | S | 64.82 | 2,382 | 154,401 | 2,012,375 | 2 M to 2 M (-0.12 %) |
May 14 2020 | MRNA | Moderna, Inc. | Hoge Stephen | President | Sell | S | 64.16 | 900 | 57,744 | 2,014,757 | 2 M to 2 M (-0.04 %) |
May 14 2020 | MRNA | Moderna, Inc. | Hoge Stephen | President | Sell | S | 62.68 | 883 | 55,346 | 2,015,657 | 2 M to 2 M (-0.04 %) |
May 14 2020 | MRNA | Moderna, Inc. | Andres Juan | See remarks | Option Exercise | M | 12.21 | 127,500 | 1,556,775 | 684,822 | |
May 14 2020 | MRNA | Moderna, Inc. | Andres Juan | See remarks | Sell | S | 66.89 | 1,300 | 86,957 | 0 | 1.3 K to 0 (-100.00 %) |
May 14 2020 | MRNA | Moderna, Inc. | Andres Juan | See remarks | Sell | S | 66.27 | 15,640 | 1,036,463 | 1,300 | 16.9 K to 1.3 K (-92.33 %) |
May 14 2020 | MRNA | Moderna, Inc. | Andres Juan | See remarks | Sell | S | 65.28 | 46,517 | 3,036,630 | 16,940 | 63.5 K to 16.9 K (-73.30 %) |
May 14 2020 | MRNA | Moderna, Inc. | Andres Juan | See remarks | Sell | S | 64.44 | 38,089 | 2,454,455 | 63,457 | 101.5 K to 63.5 K (-37.51 %) |
May 14 2020 | MRNA | Moderna, Inc. | Andres Juan | See remarks | Sell | S | 63.17 | 16,183 | 1,022,280 | 101,546 | 117.7 K to 101.5 K (-13.75 %) |
May 14 2020 | MRNA | Moderna, Inc. | Andres Juan | See remarks | Sell | S | 62.41 | 8,371 | 522,434 | 117,729 | 126.1 K to 117.7 K (-6.64 %) |
May 14 2020 | MRNA | Moderna, Inc. | Andres Juan | See remarks | Sell | S | 61.16 | 1,400 | 85,624 | 126,100 | 127.5 K to 126.1 K (-1.10 %) |
May 14 2020 | MRNA | Moderna, Inc. | Andres Juan | See remarks | Buy | M | 12.21 | 127,500 | 1,556,775 | 127,500 | 0 to 127.5 K |
May 14 2020 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Option Exercise | M | 12.21 | 125,044 | 1,526,787 | 58,442 | |
May 14 2020 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Sell | S | 62.65 | 17,744 | 1,111,662 | 0 | 17.7 K to 0 (-100.00 %) |
May 14 2020 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Sell | S | 63.59 | 19,817 | 1,260,163 | 17,744 | 37.6 K to 17.7 K (-52.76 %) |
May 14 2020 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Sell | S | 64.72 | 59,913 | 3,877,569 | 37,561 | 97.5 K to 37.6 K (-61.47 %) |
May 14 2020 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Sell | S | 65.46 | 25,905 | 1,695,741 | 97,474 | 123.4 K to 97.5 K (-21.00 %) |
May 14 2020 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Sell | S | 66.43 | 1,365 | 90,677 | 123,379 | 124.7 K to 123.4 K (-1.09 %) |
May 14 2020 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Sell | S | 67.23 | 300 | 20,169 | 124,744 | 125 K to 124.7 K (-0.24 %) |
May 14 2020 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Buy | M | 12.21 | 125,044 | 1,526,787 | 125,044 | 0 to 125 K |
May 14 2020 | MRNA | Moderna, Inc. | NABEL ELIZABETH G | Director | Sell | S | 66.00 | 30,000 | 1,980,000 | 14,344 | 44.3 K to 14.3 K (-67.65 %) |
May 13 2020 | MRNA | Moderna, Inc. | Flagship Ventures Fund IV Gene ... | Director | Sell | J | 0.00 | 2,281,179 | 0 | 0 | 2.3 M to 0 (-100.00 %) |
May 13 2020 | MRNA | Moderna, Inc. | Flagship Ventures Fund IV Gene ... | Director | Sell | J | 0.00 | 1,610,000 | 0 | 6,580,766 | 8.2 M to 6.6 M (-19.66 %) |
May 13 2020 | MRNA | Moderna, Inc. | Flagship Ventures Fund IV Gene ... | Director | Sell | J | 0.00 | 8,390,000 | 0 | 22,826,399 | 31.2 M to 22.8 M (-26.88 %) |
May 12 2020 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Buy | J | 0.00 | 55,568 | 0 | 6,740,621 | 6.7 M to 6.7 M (+0.83 %) |
May 12 2020 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 59.57 | 6,751 | 402,157 | 7,893,252 | 7.9 M to 7.9 M (-0.09 %) |
May 12 2020 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 59.57 | 3,376 | 201,108 | 9,202,903 | 9.2 M to 9.2 M (-0.04 %) |
May 12 2020 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 59.57 | 3,376 | 201,108 | 6,685,053 | 6.7 M to 6.7 M (-0.05 %) |
May 12 2020 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 59.20 | 2,109 | 124,853 | 607,546 | 609.7 K to 607.5 K (-0.35 %) |
May 12 2020 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 58.39 | 2,131 | 124,429 | 609,655 | 611.8 K to 609.7 K (-0.35 %) |
May 12 2020 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 57.13 | 1,200 | 68,556 | 611,786 | 613 K to 611.8 K (-0.20 %) |
May 12 2020 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 56.07 | 849 | 47,603 | 612,986 | 613.8 K to 613 K (-0.14 %) |
May 12 2020 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 55.04 | 2,887 | 158,900 | 613,835 | 616.7 K to 613.8 K (-0.47 %) |
May 12 2020 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 54.11 | 970 | 52,487 | 616,722 | 617.7 K to 616.7 K (-0.16 %) |
May 12 2020 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 52.84 | 900 | 47,556 | 617,692 | 618.6 K to 617.7 K (-0.15 %) |
May 06 2020 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Sell | S | 50.48 | 4,770 | 240,790 | 0 | 4.8 K to 0 (-100.00 %) |
May 04 2020 | MRNA | Moderna, Inc. | Andres Juan | See remarks | Option Exercise | M | 12.21 | 25,000 | 305,250 | 812,322 | |
May 04 2020 | MRNA | Moderna, Inc. | Andres Juan | See remarks | Sell | S | 49.69 | 3,934 | 195,480 | 0 | 3.9 K to 0 (-100.00 %) |
May 04 2020 | MRNA | Moderna, Inc. | Andres Juan | See remarks | Sell | S | 48.87 | 3,984 | 194,698 | 3,934 | 7.9 K to 3.9 K (-50.32 %) |
May 04 2020 | MRNA | Moderna, Inc. | Andres Juan | See remarks | Sell | S | 47.82 | 10,784 | 515,691 | 7,918 | 18.7 K to 7.9 K (-57.66 %) |
May 04 2020 | MRNA | Moderna, Inc. | Andres Juan | See remarks | Sell | S | 46.91 | 6,298 | 295,439 | 18,702 | 25 K to 18.7 K (-25.19 %) |
May 04 2020 | MRNA | Moderna, Inc. | Andres Juan | See remarks | Buy | M | 12.21 | 25,000 | 305,250 | 25,000 | 0 to 25 K |
May 04 2020 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 48.70 | 4,349 | 211,796 | 9,206,279 | 9.2 M to 9.2 M (-0.05 %) |
May 04 2020 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 48.70 | 8,698 | 423,593 | 7,900,003 | 7.9 M to 7.9 M (-0.11 %) |
May 04 2020 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 48.70 | 11,046 | 537,940 | 618,592 | 629.6 K to 618.6 K (-1.75 %) |
May 04 2020 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 48.70 | 4,349 | 211,796 | 6,688,429 | 6.7 M to 6.7 M (-0.06 %) |
May 01 2020 | MRNA | Moderna, Inc. | Horning Sandra | Director | Option Exercise | A | 46.37 | 18,270 | 847,180 | 18,270 | |
May 01 2020 | MRNA | Moderna, Inc. | Horning Sandra | Director | Option Exercise | A | 46.37 | 17,195 | 797,332 | 17,195 | |
Apr 30 2020 | MRNA | Moderna, Inc. | LANGER ROBERT | Director | Option Exercise | A | 46.37 | 18,270 | 847,180 | 18,270 | |
Apr 30 2020 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Option Exercise | A | 46.37 | 18,270 | 847,180 | 18,270 | |
Apr 30 2020 | MRNA | Moderna, Inc. | Berenson Stephen | Director | Option Exercise | A | 46.37 | 18,270 | 847,180 | 18,270 | |
Apr 30 2020 | MRNA | Moderna, Inc. | NABEL ELIZABETH G | Director | Option Exercise | A | 46.37 | 18,270 | 847,180 | 18,270 | |
Apr 30 2020 | MRNA | Moderna, Inc. | Nader Francois | Director | Option Exercise | A | 46.37 | 18,270 | 847,180 | 18,270 | |
Apr 30 2020 | MRNA | Moderna, Inc. | Slaoui Moncef | Director | Option Exercise | A | 46.37 | 18,270 | 847,180 | 18,270 | |
Apr 30 2020 | MRNA | Moderna, Inc. | SAGAN PAUL | Director | Option Exercise | A | 46.37 | 18,270 | 847,180 | 18,270 | |
Apr 27 2020 | MRNA | Moderna, Inc. | Hoge Stephen | President | Sell | S | 50.02 | 1,237 | 61,875 | 2,016,540 | 2 M to 2 M (-0.06 %) |
Apr 27 2020 | MRNA | Moderna, Inc. | Hoge Stephen | President | Sell | S | 49.18 | 2,963 | 145,720 | 2,017,777 | 2 M to 2 M (-0.15 %) |
Apr 27 2020 | MRNA | Moderna, Inc. | Hoge Stephen | President | Sell | S | 48.16 | 800 | 38,528 | 2,020,740 | 2 M to 2 M (-0.04 %) |
Apr 27 2020 | MRNA | Moderna, Inc. | Hoge Stephen | President | Sell | S | 50.37 | 500 | 25,185 | 2,021,540 | 2 M to 2 M (-0.02 %) |
Apr 27 2020 | MRNA | Moderna, Inc. | Hoge Stephen | President | Sell | S | 49.72 | 2,286 | 113,660 | 2,022,040 | 2 M to 2 M (-0.11 %) |
Apr 27 2020 | MRNA | Moderna, Inc. | Hoge Stephen | President | Sell | S | 48.73 | 814 | 39,666 | 2,024,326 | 2 M to 2 M (-0.04 %) |
Apr 27 2020 | MRNA | Moderna, Inc. | Hoge Stephen | President | Sell | S | 47.57 | 1,400 | 66,598 | 2,025,140 | 2 M to 2 M (-0.07 %) |
Apr 27 2020 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Sell | S | 47.15 | 10,000 | 471,500 | 4,770 | 14.8 K to 4.8 K (-67.70 %) |
Apr 27 2020 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 47.15 | 11,046 | 520,819 | 629,638 | 640.7 K to 629.6 K (-1.72 %) |
Apr 21 2020 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 45.00 | 4,269 | 192,105 | 9,210,628 | 9.2 M to 9.2 M (-0.05 %) |
Apr 21 2020 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 45.00 | 8,538 | 384,210 | 7,908,701 | 7.9 M to 7.9 M (-0.11 %) |
Apr 21 2020 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 45.00 | 4,269 | 192,105 | 6,692,778 | 6.7 M to 6.7 M (-0.06 %) |
Apr 21 2020 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 48.19 | 440 | 21,204 | 640,684 | 641.1 K to 640.7 K (-0.07 %) |
Apr 21 2020 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 47.28 | 2,449 | 115,789 | 641,124 | 643.6 K to 641.1 K (-0.38 %) |
Apr 21 2020 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 46.40 | 5,093 | 236,315 | 643,573 | 648.7 K to 643.6 K (-0.79 %) |
Apr 21 2020 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 45.50 | 2,500 | 113,750 | 648,666 | 651.2 K to 648.7 K (-0.38 %) |
Apr 21 2020 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 44.11 | 564 | 24,878 | 651,166 | 651.7 K to 651.2 K (-0.09 %) |
Apr 20 2020 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Sell | S | 48.81 | 10,000 | 488,100 | 14,770 | 24.8 K to 14.8 K (-40.37 %) |
Apr 16 2020 | MRNA | Moderna, Inc. | Andres Juan | See remarks | Option Exercise | M | 12.21 | 23,403 | 285,751 | 837,322 | |
Apr 16 2020 | MRNA | Moderna, Inc. | Andres Juan | See remarks | Sell | S | 37.78 | 9,944 | 375,684 | 0 | 9.9 K to 0 (-100.00 %) |
Apr 16 2020 | MRNA | Moderna, Inc. | Andres Juan | See remarks | Sell | S | 36.91 | 8,852 | 326,727 | 9,944 | 18.8 K to 9.9 K (-47.10 %) |
Apr 16 2020 | MRNA | Moderna, Inc. | Andres Juan | See remarks | Sell | S | 36.04 | 4,607 | 166,036 | 18,796 | 23.4 K to 18.8 K (-19.69 %) |
Apr 16 2020 | MRNA | Moderna, Inc. | Andres Juan | See remarks | Buy | M | 12.21 | 23,403 | 285,751 | 23,403 | 0 to 23.4 K |
Apr 16 2020 | MRNA | Moderna, Inc. | Kim Lorence H. | Chief Financial Off ... | Sell | S | 38.24 | 400 | 15,296 | 1,222,510 | 1.2 M to 1.2 M (-0.03 %) |
Apr 16 2020 | MRNA | Moderna, Inc. | Kim Lorence H. | Chief Financial Off ... | Sell | S | 37.62 | 7,340 | 276,131 | 1,222,910 | 1.2 M to 1.2 M (-0.60 %) |
Apr 16 2020 | MRNA | Moderna, Inc. | Kim Lorence H. | Chief Financial Off ... | Sell | S | 36.57 | 4,566 | 166,979 | 1,230,250 | 1.2 M to 1.2 M (-0.37 %) |
Apr 16 2020 | MRNA | Moderna, Inc. | Kim Lorence H. | Chief Financial Off ... | Sell | S | 35.81 | 1,517 | 54,324 | 1,234,816 | 1.2 M to 1.2 M (-0.12 %) |
Apr 16 2020 | MRNA | Moderna, Inc. | Kim Lorence H. | Chief Financial Off ... | Sell | S | 34.24 | 6,177 | 211,500 | 1,236,333 | 1.2 M to 1.2 M (-0.50 %) |
Apr 16 2020 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Gift | G | 0.00 | 2,936 | 0 | 6,697,047 | 6.7 M to 6.7 M (-0.04 %) |
Apr 14 2020 | MRNA | Moderna, Inc. | Zaks Tal Zvi | Chief Medical Offic ... | Sell | S | 32.00 | 10,000 | 320,000 | 24,770 | 34.8 K to 24.8 K (-28.76 %) |
Apr 14 2020 | MRNA | Moderna, Inc. | Hoge Stephen | President | Sell | S | 32.90 | 1,049 | 34,512 | 2,026,540 | 2 M to 2 M (-0.05 %) |
Apr 14 2020 | MRNA | Moderna, Inc. | Hoge Stephen | President | Sell | S | 32.33 | 8,951 | 289,386 | 2,027,589 | 2 M to 2 M (-0.44 %) |
Apr 14 2020 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 32.00 | 3,139 | 100,448 | 9,214,897 | 9.2 M to 9.2 M (-0.03 %) |
Apr 14 2020 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 32.00 | 6,277 | 200,864 | 7,917,239 | 7.9 M to 7.9 M (-0.08 %) |
Apr 14 2020 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 32.00 | 11,046 | 353,472 | 651,730 | 662.8 K to 651.7 K (-1.67 %) |
Apr 14 2020 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 32.00 | 3,139 | 100,448 | 6,699,983 | 6.7 M to 6.7 M (-0.05 %) |
Apr 08 2020 | MRNA | Moderna, Inc. | Andres Juan | See remarks | Option Exercise | M | 12.21 | 300 | 3,663 | 860,725 | |
Apr 08 2020 | MRNA | Moderna, Inc. | Andres Juan | See remarks | Option Exercise | M | 12.21 | 300 | 3,663 | 860,725 | |
Apr 08 2020 | MRNA | Moderna, Inc. | Andres Juan | See remarks | Sell | S | 35.13 | 300 | 10,539 | 0 | 300 to 0 (-100.00 %) |
Apr 08 2020 | MRNA | Moderna, Inc. | Andres Juan | See remarks | Sell | S | 35.13 | 300 | 10,539 | 0 | 300 to 0 (-100.00 %) |
Apr 08 2020 | MRNA | Moderna, Inc. | Andres Juan | See remarks | Buy | M | 12.21 | 300 | 3,663 | 300 | 0 to 300 |